CanniMed Therapeutics to hold talks with Aurora Cannabis

Saskatoon-based CanniMed Therapeutics Inc. is postponing a key shareholder meeting to give it time to hold talks with Aurora Cannabis Inc. which has made a hostile takeover offer for the company.

Trading in CanniMed shares (TSX:CMED) was halted pending the news.

The meeting had been set for Jan. 23 for CanniMed shareholders to vote on its plan to issue shares in its acquisition of Newstrike Resources Ltd. The meeting will now be held on Jan. 25.

Get weekly money news

Get expert insights, Q&A on markets, housing, inflation, and personal finance information delivered to you every Saturday.

Sign up for weekly money newsletter Sign Up

By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

CanniMed cautioned “there is no certainty that any such discussion will result in an agreement among the parties in respect of a transaction or in any change to the terms of Aurora’s offer.”

Aurora (TSX:ACB) has made an all-stock offer for the company worth up to $24 per share. However, the offer requires CanniMed to drop its plans to acquire Newstrike.

CanniMed has urged its shareholders to vote in favour of the Newstrike deal, but three of the Saskatoon-based company’s biggest shareholders representing 38 per cent of outstanding shares have signed lock-up agreements backing Aurora’s bid.

Newstrike shareholders (TSXV:HIP) voted overwhelmingly in favour on Wednesday of the acquisition of the company by CanniMed.